This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

3,4-DAP (Jacobus)

Jacobus Pharmaceutical Company

Drug Names(s): 3,4-diaminopyridine, amifampridine

Description: The active substance of amifampridine phosphate is a potassium channel blocker which increases the release of acetylcholine and helps the muscle to receive the nerve signals. 3,4-Diaminopyridine is an organic compound with the formula C5H3N(NH2)2. It is formally derived from pyridine by substitution of the 3 and 4 positions with an amino group.

3,4-DAP (Jacobus) News

Pink Sheet Catalyst Stumbles With Filing Of Controversial 'Breakthrough Therapy' Firdapse

Scrip arGEN-X appoints Alain Thibault CMO

Scrip Catalyst steps up to provide LEMS patients expanded Firdapse access

Scrip Catalyst plans early 2015 rolling NDA on Firdapse Phase III

Additional information available to subscribers only:

Targets
Routes
Catalysts
Designations
Events

Request a Free Demo Subscriber Login Search for another drug